GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apollomics Inc (NAS:APLMW) » Definitions » Ending Cash Position

Apollomics (Apollomics) Ending Cash Position : $32.06 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Apollomics Ending Cash Position?

Apollomics's Ending Cash Position for the quarter that ended in Dec. 2023 was $32.06 Mil.

Apollomics's quarterly Ending Cash Position declined from Dec. 2022 ($32.68 Mil) to Jun. 2023 ($25.30 Mil) but then increased from Jun. 2023 ($25.30 Mil) to Dec. 2023 ($32.06 Mil).

Apollomics's annual Ending Cash Position declined from Dec. 2021 ($46.74 Mil) to Dec. 2022 ($32.68 Mil) and declined from Dec. 2022 ($32.68 Mil) to Dec. 2023 ($32.06 Mil).

Apollomics Ending Cash Position Historical Data

The historical data trend for Apollomics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollomics Ending Cash Position Chart

Apollomics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Ending Cash Position
130.65 46.74 32.68 32.06

Apollomics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Ending Cash Position Get a 7-Day Free Trial 46.74 50.70 32.68 25.30 32.06

Apollomics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Apollomics's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=32.675+-0.619
=32.06

Apollomics's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=25.277+6.779
=32.06

Apollomics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Apollomics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Apollomics (Apollomics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apollomics Inc (NAS:APLMW) » Definitions » Ending Cash Position
Comparable Companies
ATHA STTK ACXP CARA TLSA ORMP IMMX CCCC GTHX GBIO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
APLM:USA
Address
989 East Hillsdale Boulevard, Suite 220, Foster, CA, USA, 94404
Website
https://www.apollomicsinc.com
Apollomics Inc is an innovative clinical-stage biotechnology company. It is is focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. It has a pipeline of 9 drug candidates across multiple programs, 6 of which are in the clinical stage of development.